Conto economico
BEONE MEDICINES LTD.
ONC
Riepilogo performance
Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Ricavi
|
5,343.03 | 3,810.24 | 2,500.00 | 1,415.92 | - | 308.87 | 428.21 | 198.22 | 238.39 | 1.07 |
|
Costo del venduto
|
668.54 | 594.09 | 379.92 | 286.48 | 164.91 | 70.66 | 71.19 | 28.71 | - | - |
|
Utile lordo
|
4,674.49 | 3,216.15 | 2,078.86 | 1,129.45 | -164.91 | 238.22 | 357.02 | 169.52 | 238.39 | 1.07 |
|
Spese operative
|
4,227.36 | 3,784.35 | 3,283.10 | 2,918.36 | 2,449.36 | 1,895.05 | 1,315.59 | 874.39 | 331.62 | 118.13 |
|
Ricerca e sviluppo
|
2,145.87 | 1,953.30 | 1,778.59 | 1,640.51 | 1,459.24 | 1,294.88 | 927.34 | 679.01 | 269.02 | 98.03 |
|
Spese commerciali, generali e amministrative
|
2,081.49 | 1,831.06 | 1,504.50 | 1,277.85 | 990.12 | 600.18 | 388.25 | 195.39 | 62.60 | 20.10 |
|
Altre spese operative
|
- | - | - | - | - | - | - | - | - | - |
|
Reddito operativo
|
447.14 | -568.20 | -1,204.24 | -1,788.91 | -2,614.27 | -1,656.84 | -958.57 | -704.88 | -93.23 | -117.06 |
|
Proventi/oneri non operativi
|
30.28 | -35.20 | -378.40 | 172.12 | -1,175.68 | -38.64 | -14.98 | -704.88 | -93.23 | 2.10 |
|
Proventi da interessi
|
70.51 | - | - | - | - | - | - | - | - | - |
|
Oneri finanziari
|
49.95 | 46.89 | 20.80 | 21.70 | 29.26 | 18.31 | 4.73 | 2.25 | 1.26 | 0.85 |
|
Altri proventi/oneri non operativi
|
-14.98 | -10.28 | -0.43 | 27.71 | 15.90 | 37.49 | 7.17 | 1.99 | 11.46 | 0.44 |
|
Risultato prima delle imposte
|
416.85 | -533.00 | -825.84 | -1,961.04 | -1,438.59 | -1,618.19 | -943.59 | 0.00 | 0.00 | 0.21 |
|
Imposte sul reddito
|
129.92 | 111.79 | 55.87 | 42.78 | -25.23 | -21.29 | 5.04 | 673.77 | 93.11 | 0.05 |
|
Utile di pertinenza di terzi
|
- | - | - | 0.00 | 0.00 | -3.62 | -1.95 | -0.26 | -0.19 | - |
|
Utile netto
|
286.93 | -644.79 | -881.71 | -2,003.82 | -1,413.35 | -1,596.91 | -948.63 | -673.77 | -93.11 | -119.22 |
Informazioni supplementari
Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Ammortamenti e svalutazioni
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
588.82 | -396.44 | -1,116.56 | -1,722.64 | -2,567.81 | -1,625.05 | -939.95 | -694.49 | -88.48 | -117.06 |
|
Utile per azione (base)
|
0.20 | -0.47 | -0.65 | -1.49 | -1.17 | - | - | - | - | - |
|
Utile per azione diluito
|
0.19 | -0.47 | -0.65 | -1.49 | -1.17 | - | - | - | - | - |
|
Media ponderata azioni
|
1,417.80 | 1,368.75 | 1,357.03 | 1,340.73 | 1,206.21 | - | - | - | - | - |
|
Media ponderata diluita azioni
|
1,474.83 | 1,368.75 | 1,357.03 | 1,340.73 | 1,206.21 | - | - | - | - | - |
|
Conto economico complessivo
|
357.74 | -694.33 | - | -2,099.18 | -1,402.35 | -1,581.96 | -958.16 | -672.03 | -92.64 | -118.35 |